News Daily News La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes Yael L. Maxwell October 28, 2016
News Daily News FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke Yael L. Maxwell October 28, 2016
News Daily News FDA Expands Indications for Two Endovascular Stroke Therapies Todd Neale September 06, 2016
News Daily News TAVR as an Option for Intermediate-Risk Patients: Physicians Respond Yael L. Maxwell August 24, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016
News Daily News Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients Todd Neale August 01, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Daily News Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke Shelley Wood May 25, 2016